First Citizens Bank & Trust’s Precision BioSciences DTIL Stock Holding History

First Citizens Bank & Trust’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,833	Closed	-$31K	–	437
2023 Q4	$31K	Hold	2,833	–	–	﹤0.01%	356
2023 Q3	$29K	Hold	2,833	–	–	﹤0.01%	347
2023 Q2	$44.7K	Hold	2,833	–	–	﹤0.01%	349
2023 Q1	$64.1K	Hold	2,833	–	–	﹤0.01%	326
2022 Q4	$101K	Hold	2,833	–	–	﹤0.01%	313
2022 Q3	$111K	Hold	2,833	–	–	﹤0.01%	301
2022 Q2	$136K	Hold	2,833	–	–	﹤0.01%	390
2022 Q1	$262K	Hold	2,833	–	–	0.01%	340
2021 Q4	$629K	Hold	2,833	–	–	0.02%	206
2021 Q3	$981K	Hold	2,833	–	–	0.05%	169
2021 Q2	$1.06M	Buy	+2,833	New	+$851K	0.05%	159

Other funds holding DTIL

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

First Citizens Bank & Trust's DTIL Position: Q1 2024 in Review

First Citizens Bank & Trust sold out of Precision BioSciences (DTIL) in Q1 2024, closing a stake of 2,833 shares — an estimated $31K sold.

First Citizens Bank & Trust first reported a position in DTIL in Q2 2021 and held it in 11 quarters. The position peaked at $1.06M in Q2 2021. 43 funds tracked by Wall St. Rank hold DTIL as of Q1 2024.

First Citizens Bank & Trust reported no remaining Precision BioSciences position as of Q1 2024 after selling out during the quarter.
First Citizens Bank & Trust sold 2,833 Precision BioSciences shares in Q1 2024, an estimated $31K.
First Citizens Bank & Trust first reported a position in Precision BioSciences in Q2 2021 and held it in 11 quarters.
First Citizens Bank & Trust's Precision BioSciences position peaked at $1.06M in Q2 2021.
43 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2024.

Based on First Citizens Bank & Trust's 13F filing for Q1 2024, filed 15 Apr 2024.